Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |